Use of Eylea for the Treatment of an Optic Nerve Hemangioma
Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a single patient investigative treatment study. The patient was diagnosed with a
retinal tumor in one eye. In the last 2 years, the patient has been treated with all
available and conventional therapies, including intraocular injections of Avastin and
Lucentis, steroids, and photodynamic therapy. Any positive results were short-term, and
caused an eventual decline in central vision. Aflibercept has been shown to be effective
against the growth of new vessels, secondary to macular degeneration. This study proposes
that it may also be more effective in treating this particular patient and case. The study
treatment plan is for 6 months initially, with the intention to continue treatment.